Business Services Industry
Medegen Prevails on Appeal in ICU Medical Inc. Patent Infringement Case
Business Wire, Dec 2, 2008
Leader in Infusion Therapy Medical Products Protects Proprietary Innovation
ONTARIO, Calif. -- Medegen, a leading innovator in infusion therapy medical products, announced today that it has won an important legal victory in the United States Court of Appeals for the Federal Circuit in Washington, D.C. The appellate court's decision reverses a judgment issued by a district court judge in the Central District of California of patent non-infringement entered in favor of ICU Medical Inc. (NASDAQ: ICUI).
Medegen argued successfully that the decision below inappropriately narrowed the definition of key terms of one of its patents (U.S. Patent No. 5,730,418). This patent covers a number of Medegen's novel inventions in needleless connectors, including the use of positive displacement technology, which reduces the occurrence of common vascular access device-related complications. The case is now returned to the lower court with the appellate court having interpreted key claim language as Medegen had requested.
"Medegen's intellectual property is valuable, and we feel strongly about protecting our innovations. We are encouraged by the successful outcome of our appeal," said Jeffrey Goble, president of Medegen.
About Medegen Inc.
Medegen is a leading innovator in infusion therapy, focused on helping hospitals drive greater clinical performance for improved patient care. The growing company provides clinically superior medical products and reliable, cost-effective manufacturing services to the medical community through its three operating units: Manufacturing Services, Maximus and KippMed. Manufacturing Services provides cost-effective contract manufacturing solutions to medical device, drug delivery and pharmaceutical companies. KippMed manufactures and markets IV therapy components for the OEM market, drawing from a 25-year history in IV component supply. Maximus develops, manufactures and markets needleless intravenous therapy products for the acute care market. The Maximus line of medical products features patent-protected technologies which improve patient outcomes and greatly reduce bloodstream infection rates. Medegen is headquartered in Ontario, Calif., with executive offices in Scottsdale, Ariz., and operations in Tijuana, Mexico. For more visit http://www.medegen.com/.>
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
Most Popular Business Publications
Content provided in partnership with
